New agents for acute myelogenous leukemia.

Zwiebel, J A

Zwiebel, J A.

Affiliation

Zwiebel JA; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA.

Leukemia ; 14(3): 488-90, 2000 Mar.

Article in En | MEDLINE | ID: mdl-10720147

Subject(s)

Antineoplastic Agents/therapeutic use; Leukemia, Myeloid/drug therapy; Saccharomyces cerevisiae Proteins; Acetylation/drug effects; Acetyltransferases/metabolism; Acute Disease; Angiogenesis Inhibitors/therapeutic use; Antineoplastic Agents/pharmacology; Clinical Trials as Topic; Enzyme Inhibitors/therapeutic use; Forecasting; Gene Expression Regulation, Leukemic/drug effects; Histone Acetyltransferases; Histone Deacetylases/metabolism; Histones/metabolism; Humans; Neoplasm Proteins/antagonists & inhibitors; Neoplasm Proteins/metabolism; Protein Kinase C/antagonists & inhibitors; Protein Processing, Post-Translational/drug effects; Retinoids/pharmacology; Retinoids/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid / Saccharomyces cerevisiae Proteins / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2000 Document type: Article Affiliation country: United States Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links